CME to Sue CFTC Over Perpetual Futures Approval
- CME Chief Executive Terrence Duffy announced plans to sue the U.S. Commodity Futures Trading Commission (CFTC).
- The lawsuit follows the CFTC’s approval of Kalshi’s perpetual futures product, which Duffy claims violates the Dodd-Frank Act.
- Duffy stated that the approved products should be classified as swaps, not futures, due to payment exchanges between parties.
- He emphasized that CME needs clarity on regulations before considering its own perpetual futures contracts.
- Duffy is set to step down from his role next year, indicating potential changes in CME’s strategy.
The CFTC’s decision has raised concerns about regulatory compliance under the Dodd-Frank Act, particularly regarding how products are categorized as swaps or futures. This legal action reflects ongoing tensions in the derivatives market and highlights uncertainties in regulatory frameworks.
CME’s planned lawsuit against the CFTC stems from its approval of a product that Duffy argues does not meet necessary legal definitions, emphasizing significant implications for future trading practices and compliance standards. (Source)
